Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Pharmacy Facelift: How Walgreens and CVS Aim to Boost Profits

by Team Lumida
May 17, 2024
in Markets, News
Reading Time: 4 mins read
A A
0
woman with face mask holding an alcohol bottle

Photo by Anna Tarazevich on Pexels.com

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

  1. Walgreens and CVS are redesigning stores to emphasize health and wellness.
  2. Rising competition and falling margins drive these changes.
  3. Investors should watch for potential improvements in profitability and customer satisfaction.

What Happened?

Walgreens and CVS are drastically revamping their store layouts to focus on health and wellness, aiming to counter sagging performance. Walgreens, for example, is testing a new store design in Aubrey, Texas, where the pharmacy counter is moved to the front, and customers use self-service kiosks.

CVS is integrating its Oak Street Health primary-care centers into some stores. Both chains have seen significant declines in operating margins, with Walgreens’ U.S. pharmacy operating margin dropping to -5% last year. These redesign efforts are part of broader strategies to improve efficiency and customer experience amid fierce competition from Amazon, Dollar General, and Walmart.

Why It Matters?

These changes are crucial as both Walgreens and CVS struggle with falling margins and investor dissatisfaction. Walgreens’ shares have plummeted 77% over the past decade, and CVS’ shares have dropped 26%.

By making pharmacies more customer-friendly and efficient, they aim to attract more customers and boost profitability. These efforts are essential for long-term sustainability, especially given the increasing role of pharmacists in healthcare services, such as vaccinations and testing.

What’s Next?

Investors should monitor the success of these pilot stores and any subsequent rollouts. If these new designs prove effective, we could see a broader implementation, potentially improving the financial outlook for both companies.

Additionally, keep an eye on the labor situation; reducing pharmacists’ workloads could enhance service quality and customer satisfaction. The success of these initiatives could also pressure competitors to innovate, potentially reshaping the entire pharmacy landscape.

Source: Bloomberg
Previous Post

Medicare Shakeup: Policy Changes Rattle Big Insurers

Next Post

Revolutionizing AI: How DePIN is Solving Robots’ Biggest Blind Spot

Recommended For You

BofA’s Hartnett Stays Risk-Off Until Mid-November and Says Markets Still Need to Price a Democratic Sweep

by Team Lumida
1 day ago

Bank of America’s Michael Hartnett expects a down-in-yields, down-in-stocks, down-in-dollar trade until mid-November as AI and midterm jitters linger.

Read more

LKQ Ousts Its CEO and Warns Q3 Earnings Will Fall Well Short After a 9.8% Drop in European Revenue

by Team Lumida
1 day ago

LKQ expects Q3 adjusted EPS of 47 to 53 cents versus the 69 cents expected, ousted CEO Justin Jude and hired Alvarez & Marsal to review Europe.

Read more

SLB Jumps as Much as 6% as Middle East Revenue Rises 13% and It Sees Venezuela Sales More Than Doubling by Year-End

by Team Lumida
1 day ago

SLB beat estimates with 64 cents of adjusted EPS as Middle East revenue rose 13%, and its CEO sees a very compelling 2027 with Venezuela a key growth...

Read more

GM Is Headed for Its Worst Week Since January 2025, but Not One Analyst Tracked by Bloomberg Says Sell

by Team Lumida
1 day ago

GM shares fell 8% this week through Thursday, on pace for the biggest weekly drop since January 2025, yet StoneX, BNP Paribas, Evercore and RBC say buy the...

Read more

Longtime Chipotle Bull TD Cowen Moves to Hold With a Street-Low $32 Target as Fourth-Quarter Sales Soften

by Team Lumida
1 day ago

TD Cowen’s Andrew Charles, a Chipotle bull since 2019, cut the stock to hold with a Street-low $32 target, citing a soft start to the fourth quarter.

Read more

Kalshi Plans the Only CPI Futures for a December Launch, Pitching Banks and Hedge Funds in a Challenge to CME

by Team Lumida
1 day ago
Kalshi logo over an abstract red swirl graphic

Kalshi is targeting a December launch for futures on headline and core CPI, and hired the “Inflation Guy” Michael Ashton to pitch big banks and hedge funds.

Read more

Americans’ Inflation Expectations Hit the Highest Since May, and Nearly 70% Now Expect Interest Rates to Rise

by Team Lumida
1 day ago
US Consumer Sentiment Plummets to Eight-Month Low

University of Michigan data show year-ahead inflation expectations at 4.7% and long-run at 3.5%, while nearly 70% expect interest rates to rise.

Read more

SEC Examiners Will Zero In on Private Fund Valuations and AI-Driven Cyberattacks, and Add the PCAOB to Their Targets

by Team Lumida
1 day ago
U.S. Securities and Exchange Commission seal against an orange block background

The SEC’s new examination priorities target private fund fees, expenses and valuations, AI-related cyber risks and complex retail products, and add the PCAOB.

Read more

US Business Activity Stays Near a Multi-Year High as Selling Prices Rise at the Fastest Pace in More Than Four Years

by Team Lumida
1 day ago

S&P Global’s flash US composite PMI slipped to 57.6 in October, the second-highest since 2022, as selling prices rose at the fastest pace in over four years.

Read more

US Air Travel Is Headed for Its First Annual Decline Since 2020 as Fares Jump More Than 22%, and Airlines Say That’s Fine

by Team Lumida
1 day ago

US airport screenings are on track for their first annual decline since 2020 as fares jump more than 22%, but airlines say yield matters more than full planes.

Read more
Next Post

Revolutionizing AI: How DePIN is Solving Robots’ Biggest Blind Spot

NFT Nightmare: Dolce & Gabbana Sued Over NFT Misstep

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

S&P 500’s Big Earnings Test: Will Tech Slowdown Derail Gains?

US Futures Dip: What’s Next After S&P 500’s Record Close?

September 25, 2024
turned on flat screen monitor

Treasury Bonds Close January Higher Despite Trump’s Tariff Threats

January 31, 2025
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

U.S. Foreign Aid Freeze Hampers Critical China-Focused Research, Weakening Global Scrutiny

February 27, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018